Verantos to Present on Reliable Real-World Evidence at ISPE 41st Annual Meeting
MENLO PARK, Calif.--(BUSINESS WIRE)--Verantos, a leader in producing high-validity real-world evidence (RWE) at scale, announced it will present practical methods for generating reliable RWE at the International Society for Pharmacoepidemiology (ISPE) 41st Annual Meeting in Washington, D.C.
Presentation Details and Key Topics
Verantos CEO Dan Riskin will discuss strategies to achieve fit-for-use real-world data (RWD) drawn from collaborations with large pharmaceutical partners and from the FDA-sponsored, Verantos-led TRUST and VERIFY studies. His presentation is titled “Data reliability: implementing accuracy, completeness, and traceability in practice.”
Riskin will describe how the emphasis should be on improving data reliability—not only measuring it—and doing so with peer-reviewed, published methods to prevent manipulation of metrics. He will note that evidence based on low-quality or unvalidated RWD remains questionable.
Symposium Snapshot
- Event: ISPE 41st Annual Meeting, Washington, D.C.
- Session: Real-world ...